Fig. 4From: α-linolenic acid and docosahexaenoic acid, alone and combined with trastuzumab, reduce HER2-overexpressing breast cancer cell growth but differentially regulate HER2 signaling pathwaysEffect of DHA (50 and 100 μM) and TRAS, alone and in combination, on the expression of total and phosphorylated HER2, Akt and MAPK after 96 h of treatment of BT-474 cells. (n = 5-6). Representative blots are displayed. For HER2 protein biomarkers, blot images were cropped and rearranged for consistency of presentation of treatment groups. Bands for each biomarkers are from the same blotBack to article page